Respiratory panel denied by insurance

The major insurance payers have been denying a respiratory panel, and our patients have been incurring unanticipated expense associated with the order. Many practitioners have requested that the test be credited to defray the patient paying for the denial, and this becomes a cost to the organization. The cost to the patient is between $750 and $800.

The panel being denied is: EAP 516601 Respiratory Panel by Molecular Assay (22 target assay).

To avoid the denial, the lab is communicating an alternative order that is available and is covered by insurance. Please update your preference lists to include the smaller panels that are covered by the payers.

The alternative panel being covered is: EAP 520272 SARS-CoV-2, Flu A/B/RSV by Molecular Assay (4 target assay).

Thank you for your help in lowering costs for your patients and your hospital. Please contact your onsite Lab director for more information.